Hypothalamic regulation of energy homeostasis.
暂无分享,去创建一个
[1] D. Porte,et al. Localization of insulin receptor mRNA in rat brain by in situ hybridization. , 1990, Endocrinology.
[2] M. Herkenham,et al. Arcuate nucleus neurons that project to the hypothalamic paraventricular nucleus: Neuropeptidergic identity and consequences of adrenalectomy on mRNA levels in the rat , 1995, The Journal of comparative neurology.
[3] C. Saper,et al. Distributions of leptin receptor mRNA isoforms in the rat brain , 1998, The Journal of comparative neurology.
[4] R. Broadwell,et al. Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood , 1976, The Journal of comparative neurology.
[5] H. Herzog,et al. Regional distribution of Y‐receptor subtype mRNAs in rat brain , 1999, The European journal of neuroscience.
[6] J. Falk. Physiology and Behavior. , 1973 .
[7] J. Mcdonald,et al. Neuropeptide Y Actions on Reproductive and Endocrine Functions , 1993 .
[8] R. Boston,et al. Metabolic Consequences of Prolonged Hyperinsulinemia in Humans: Evidence for Induction of Insulin Insensitivity , 1986, Diabetes.
[9] R. Rizza,et al. Effects of glucocorticoids on carbohydrate metabolism. , 1988, Diabetes/metabolism reviews.
[10] F. Assimacopoulos-Jeannet,et al. The hormonal and metabolic basis of experimental obesity. , 1976, Clinics in endocrinology and metabolism.
[11] G. Thomas,et al. Hypothalamic Y2 receptors regulate bone formation. , 2002, The Journal of clinical investigation.
[12] F. Rohner-Jeanrenaud,et al. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. , 1993, Endocrinology.
[13] R. Emsley,et al. Serotonergic agents in the treatment of hypothalamic obesity syndrome: a case report. , 1996, International Journal of Eating Disorders.
[14] M. Ghatei,et al. Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. , 1993, Endocrinology.
[15] E. Arenas,et al. Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor , 1999, Nature Medicine.
[16] R. Palmiter,et al. Role of the Y5 neuropeptide Y receptor in feeding and obesity , 1998, Nature Medicine.
[17] T. Pedrazzini,et al. Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor , 1998, Nature Medicine.
[18] Rachel L. Batterham,et al. Gut hormone PYY3-36 physiologically inhibits food intake , 2002, Nature.
[19] G. Bray,et al. Sympathetic activity following paraventricular or ventromedial hypothalamic lesions in rats , 1988, Brain Research Bulletin.
[20] M. Zemel,et al. Diazoxide down‐regulates leptin and lipid metabolizing enzymes in adipose tissue of Zucker rats , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] Allen S Levine,et al. Divergence of the feeding and thermogenic pathways influenced by NPY in the hypothalamic PVN of the rat. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[22] A. Sclafani. Neural pathways involved in the ventromedial hypothalamic lesion syndrome in the rat. , 1971, Journal of comparative and physiological psychology.
[23] S. Corbett,et al. Thermogenesis after lateral hypothalamic lesions: contributions of brown adipose tissue. , 1988, The American journal of physiology.
[24] M. Kasuga,et al. Cocaine-Amphetamine-Regulated Transcript Influences Energy Metabolism, Anxiety and Gastric Emptying in Mice , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[25] J. Ronan,et al. Centrally administered MTII affects feeding, drinking, temperature, and activity in the Sprague-Dawley rat. , 2000, Journal of applied physiology.
[26] A. Pontiroli,et al. Patients with insulinoma show insulin resistance in the absence of arterial hypertension , 1992, Diabetologia.
[27] L. Vécsei,et al. Opposite effects of centrally administered neuropeptide Y (NPY) on locomotor activity of spontaneously hypertensive (SH) and normal rats. , 1989, Acta physiologica Scandinavica.
[28] C. Wahlestedt,et al. The Biology of Neuropeptide Y and Related Peptides , 1993, Contemporary Neuroscience.
[29] W. Rand,et al. a-Melanocyte-Stimulating Hormone Is Contained in Nerve Terminals Innervating Thyrotropin-Releasing Hormone-Synthesizing Neurons in the Hypothalamic Paraventricular Nucleus and Prevents Fasting-Induced Suppression of Prothyrotropin-Releasing Hormone Gene Expression , 2000 .
[30] S. Bloom,et al. Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals. , 2001, Diabetes.
[31] D. Smith,et al. Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. , 2000, Diabetes.
[32] G. Cooney,et al. Central but not peripheral glucocorticoid infusion in adrenalectomized male rats increases basal and substrate-induced insulinemia through a parasympathetic pathway. , 2001, Obesity research.
[33] R. Lechan,et al. Agouti-Related Protein Containing Nerve Terminals Innervate Thyrotropin-Releasing Hormone Neurons in the Hypothalamic Paraventricular Nucleus. , 1999, Endocrinology.
[34] F. Assimacopoulos-Jeannet,et al. Hyperinsulinemia increases the amount of GLUT4 mRNA in white adipose tissue and decreases that of muscles: a clue for increased fat depot and insulin resistance. , 1990, Endocrinology.
[35] D. Coscina,et al. Dissociated feeding and hypothermic effects of neuropeptide Y in the paraventricular and perifornical hypothalamus , 1995, Peptides.
[36] S. Bloom,et al. Printed in U.S.A. Copyright © 2001 by The Endocrine Society Evidence of an Orexigenic Role for Cocaine- and Amphetamine-Regulated Transcript after Administration into Discrete Hypothalamic Nuclei , 2022 .
[37] I. Baird. Progress in Obesity Research 1990 , 1992 .
[38] C. Wahlestedt,et al. Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptides , 1986, Regulatory Peptides.
[39] R. Lechan,et al. Printed in U.S.A. Copyright © 1998 by The Endocrine Society The Arcuate Nucleus Is the Major Source for Neuropeptide Y-Innervation of Thyrotropin-Releasing Hormone Neurons in the Hypothalamic Paraventricular Nucleus* , 2022 .
[40] S. Woods,et al. Intraventricular corticosterone increases the rate of body weight gain in underweight adrenalectomized rats. , 1992, Endocrinology.
[41] C. Strader,et al. Activation of the NPY Y5 receptor regulates both feeding and energy expenditure. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.
[42] S. Joseph,et al. Arcuate nucleus projections to brainstem regions which modulate nociception , 1991, Journal of Chemical Neuroanatomy.
[43] P. J. Larsen,et al. Hypothalamic CART is a new anorectic peptide regulated by leptin , 1998, Nature.
[44] G. Barsh,et al. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area , 1998, The Journal of comparative neurology.
[45] T. Hori,et al. Thermoregulatory effect of intracerebral injections of neuropeptide Y in rats at different environmental temperatures. , 1994, General pharmacology.
[46] J. Roberts,et al. Adrenalectomy reverses obese phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice. , 2000, Diabetes.
[47] R. Palmiter,et al. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y , 1996, Nature.
[48] M. Kuhar,et al. Intra-ventral tegmental area injection of rat cocaine and amphetamine-regulated transcript peptide 55-102 induces locomotor activity and promotes conditioned place preference. , 2000, The Journal of pharmacology and experimental therapeutics.
[49] T. Hökfelt,et al. Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[50] S. Bloom,et al. The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. , 2000, The Journal of clinical investigation.
[51] Michael W. Schwartz,et al. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons , 1998, Nature Neuroscience.
[52] T. Hökfelt,et al. Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. , 1997, Neuroendocrinology.
[53] R. Cone,et al. Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.
[54] J. Halaas,et al. Leptin and the regulation of body weight in mammals , 1998, Nature.
[55] P. J. Larsen,et al. Chronic Intracerebroventricular Administration of Recombinant CART(42–89) Peptide Inhibits Food Intake and Causes Weight Loss in Lean and Obese Zucker (fa/fa) Rats , 2000 .
[56] W. Rand,et al. Printed in U.S.A. Copyright © 2001 by The Endocrine Society Neuropeptide Y Has a Central Inhibitory Action on the Hypothalamic-Pituitary-Thyroid Axis* , 2022 .
[57] Katherine S Brown,et al. Central injection in rats of α-melanocyte-stimulating hormone analog: effects on food intake and brain Fos , 1998, Regulatory Peptides.
[58] G. Barsh,et al. Obesity, diabetes, and neoplasia in yellow Avy/‐ mice: ectopic expression of the agouti gene , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[59] D. Johnson,et al. Expression cloning of a human brain neuropeptide Y Y2 receptor , 1996, Regulatory Peptides.
[60] R. Cone,et al. Knockout models resulting in the development of obesity. , 2001, Trends in genetics : TIG.
[61] G. Cooney,et al. Chronic central melanocortin-4 receptor antagonism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways. , 2002, Diabetes.
[62] I. McGregor,et al. Metabolic effects of neuropeptide Y injections into the paraventricular nucleus of the hypothalamus , 1990, Brain Research.
[63] S. Leibowitz,et al. The perifornical area: the major focus of (a) patchily distributed hypothalamic neuropeptide Y-sensitive feeding system(s) , 1993, Brain Research.
[64] J. Wikberg,et al. Long-term administration of MC4 receptor antagonist HS014 causes hyperphagia and obesity in rats. , 1999, Neuroreport.
[65] H. Herzog,et al. Inhibitory effects of central neuropeptide Y on the somatotropic and gonadotropic axes in male rats are independent of adrenal hormones , 2001, Peptides.
[66] Y. Deshaies,et al. Effects of corticotropin-releasing factor on energy balance in rats are sex dependent. , 1989, American Journal of Physiology.
[67] R. Palmiter,et al. Attenuation of the Obesity Syndrome of ob/ob Mice by the Loss of Neuropeptide Y , 1996, Science.
[68] S. O’Rahilly,et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. , 2000, The Journal of clinical investigation.
[69] M. Aubert,et al. Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes. , 2000, Endocrinology.
[70] M. Kuhar,et al. Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo–pituitary axes in vitro and in vivo in male rats , 2001, Brain Research.
[71] S. Leibowitz,et al. Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity , 1986, Peptides.
[72] D. Macneil,et al. Neither Agouti-Related Protein nor Neuropeptide Y Is Critically Required for the Regulation of Energy Homeostasis in Mice , 2002, Molecular and Cellular Biology.
[73] G. Barsh,et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. , 1997, Science.
[74] A. N. van den Pol,et al. Multiple NPY Receptors Coexist in Pre- and Postsynaptic Sites: Inhibition of GABA Release in Isolated Self-Innervating SCN Neurons , 1996, The Journal of Neuroscience.
[75] T. Kowalski,et al. Neuropeptide Y Overexpression in the Preweanling Zucker (fa/fa) Rat , 1999, Physiology & Behavior.
[76] R. Cone,et al. Independent and additive effects of central POMC and leptin pathways on murine obesity. , 1997, Science.
[77] A. Levine,et al. Effect of CART in the hypothalamic paraventricular nucleus on feeding and uncoupling protein gene expression , 2000, Neuroreport.
[78] R. Cone,et al. Genetic models of obesity and energy balance in the mouse. , 2000, Annual review of genetics.
[79] T. Horvath,et al. Segregation of the intra- and extrahypothalamic neuropeptide Y and catecholaminergic inputs on paraventricular neurons, including those producing thyrotropin-releasing hormone , 1998, Regulatory Peptides.
[80] J. Peters,et al. Environmental contributions to the obesity epidemic. , 1998, Science.
[81] S. Kalra,et al. c-fos expression in the rat brain following central administration of neuropeptide Y and effects of food consumption , 1994, Brain Research.
[82] S. O’Rahilly,et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans , 1997, Nature.
[83] F. Rohner-Jeanrenaud. A neuroendocrine reappraisal of the dual-centre hypothesis: its implications for obesity and insulin resistance. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[84] A. Debons,et al. Gold thioglucose-induced hypothalamic damage, hyperphagia, and obesity: dependence on the adrenal gland. , 1982, Endocrinology.
[85] R. Palmiter,et al. A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[86] G. Bray,et al. Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. , 1991, The American journal of physiology.
[87] R. Seeley,et al. Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[88] F. Rohner-Jeanrenaud,et al. The Leptin-Like Effects of 3-d Peripheral Administration of a Melanocortin Agonist Are More Marked in Genetically Obese Zucker (fa/fa) than in Lean Rats. , 2002, Endocrinology.
[89] Motonao Nakamura,et al. Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[90] O. Boss,et al. Induction of obesity and hyperleptinemia by central glucocorticoid infusion in the rat. , 1999, Diabetes.
[91] J. Rodin,et al. Effect of chronic stress and exogenous glucocorticoids on regional fat distribution and metabolism , 1992, Physiology & Behavior.
[92] M. Dallman,et al. Feast and Famine: Critical Role of Glucocorticoids with Insulin in Daily Energy Flow , 1993, Frontiers in Neuroendocrinology.
[93] L. Yaswen,et al. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin , 1999, Nature Medicine.
[94] E. Ravussin,et al. Chronic central infusion of cocaine- and amphetamine-regulated transcript (CART 55-102): effects on body weight homeostasis in lean and high-fat-fed obese rats , 2002, International Journal of Obesity.
[95] B. Hamilton,et al. Chronic application of MTII in a rat model of obesity results in sustained weight loss. , 2002, Obesity research.
[96] Gareth Williams,et al. The hypothalamus and the control of energy homeostasis Different circuits, different purposes , 2001, Physiology & Behavior.
[97] L. Pénicaud,et al. In vivo metabolic changes as studied longitudinally after ventromedial hypothalamic lesions. , 1986, The American journal of physiology.
[98] M. Brownstein,et al. Distribution of α-melanocyte-stimulating hormone in the rat brain: Evidence that α-MSH-containing cells in the arcuate region send projections to extrahypothalamic areas , 1979, Brain Research.
[99] S. Woods,et al. Long-term orexigenic effects of AgRP-(83---132) involve mechanisms other than melanocortin receptor blockade. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.
[100] J. Shutter,et al. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. , 1997, Genes & development.
[101] S. Hisano,et al. Localization of glucocorticoid receptor in neuropeptide Y-containing neurons in the arcuate nucleus of the rat hypothalamus , 1988, Neuroscience Letters.
[102] M. Hudson,et al. Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. , 1999, The Journal of pediatrics.
[103] T. Hökfelt,et al. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[104] K. Hall,et al. Physiology and behaviour , 1965 .
[105] T. Hökfelt,et al. Neuropeptide Y Innervation and Neuropeptide-Y-Y1-Receptor-Expressing Neurons in the Paraventricular Hypothalamic Nucleus of the Mouse , 1999, Neuroendocrinology.